Posted by Michael Wonder on 11 Apr 2026
MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronaemia syndrome
10 April 2026 - The MHRA has today approved olezarsen (Tryngolza) to help treat adults with familial chylomicronaemia syndrome.
This product was submitted and approved via IRP Route B.
